Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
HIMS
Hims & Hers
$52.54
Login to see Hims & Hers (HIMS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Investors confidence is positive
Trading below its fair value
Risk Analysis
Downgraded on weak valued
Chart
$47.79 (+9.94%)
$52.03 (+0.98%)
$61.73 (-14.89%)
$22.15 (+137.20%)
HIMS has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
High volatilty
HIMS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
HIMS Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HIMS Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayHIMS Earnings
The TTM reflects 12-month period, providing review of HIMS financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is HIMS current stock price?
What are HIMS stock strengths?
What risks are associated with HIMS stock?
When is HIMS next earnings report?
What is HIMS market cap and volume?
What is HIMS's current Stock IQ?
Should I buy HIMS stock right now?
Is HIMS a Strong Buy right now?
What does a 'Strong Buy' rating mean for HIMS?
What does a 'Strong Sell' rating mean for HIMS?
What factors influence HIMS's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
HIMS
Hims & Hers
Current Price
$52.54
Stock Insights
Strengths
Earnings are forecast to grow
Investors confidence is positive
Trading below its fair value
Risk Analysis
Downgraded on weak valued
Login to unlock Hims & Hers (HIMS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$47.79 (+9.94%)
$52.03 (+0.98%)
$61.73 (-14.89%)
$22.15 (+137.20%)
HIMS Analysts Opinion
HIMS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
HIMS Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HIMS Street view is unimpressive and have negative views on the near-term outlook
HIMS has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
High volatilty
Average key support and resistance price levels.
Login to displayHIMS Earnings
The TTM data reflects the most recent 12-month period, providing overview of HIMS financial performance.
HIMS Financial Health
The company financial health has moderately improved over the past year
Financial Score
HIMS Latest Analysis
Why Hims & Hers Stock Slipped Today. Key PointsThe company is replacing its COO.
Today
Hims & Hers Health Inc. (HIMS) Laps the Stock Market: Heres Why. The latest trading day saw Hims & Hers Health Inc. (HIMS) settling at $59.12 representing a 1.23% change from its previous close.
Mon Sep 29, 2025
Hims & Hers Powers YieldMaxs Latest Options-Based Income ETF. income-oriented funds on Tuesday with the introduction of the ). The new fund aims to provide current income by utilizing options-based strategies related to ) a prominent consumer health and wellness business.HIMS stock is showing exceptional strength. Unlike other equity ETFs HIYY does not actually invest in Hims &. Hers shares. Instead the fund uses options strategies in an effort to provide advanced income streams for sharehol
Fri Sep 26, 2025
Hims & Hers Health Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It. Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.
Fri Sep 26, 2025
Im Downgrading Hims & Hers Stock. Hims &. Hers Health (NYSE: HIMS) stock is soaring since I rated it a buy.
Wed Sep 24, 2025
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation. HIMS is scaling globally with AI-powered care new treatments and an $870 million boost to expand its digital ecosystem.
Mon Sep 22, 2025
Hims & Hers Is An Interesting Story But Not The One I Signed Up For - Downgrade.
Thu Sep 18, 2025
Hims & Hers Healths Options Frenzy: What You Need to Know. Financial giants have made a conspicuous bearish move on Hims &. Hers Health. Our analysis of options history for Hims &. Hers Health (NYSE:) revealed 13 unusual trades.Delving into the details we found 38% of traders were ish while 53% showed bearish tendencies. Out of all the trades we spotted 2 were puts with a value of $87325 and 11 were calls valued at $594055.After evaluating the trading volumes and Open Interest it'.s ev
Wed Sep 17, 2025
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic Wegovy. ) stock is trading lower on Tuesday. The United States Food and Drug Administration (FDA) issued a warning letter to Hims &. Hers Health dated Sept. 9 addressed to the company’.s CEO HIMS is encountering selling pressure. The FDA flagged misleading claims made by Hims &. Hers Health regarding its compounded semaglutide products. Semaglutide is an active ingredient in ) flagship Wegovy and Ozempic.In a warn
Tue Sep 16, 2025
Huge News for Hims & Hers Stock. Hims &. Hers (NYSE: HIMS) is adding another specialty in an effort to build out its healthcare platform. The company has brought testosterone to the market the first big addition since weight loss in 2023. This is the kind of move that could drive the companys growth which
Tue Sep 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HIMS Stock trends
HIMS Stock performance
HIMS Stock analysis
HIMS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings